Chimeros chimeros.com


Public lists: Pharma Startups (4732)

Chimeros is developing a biologics approach to enable delivery of polynucleotide therapeutics such as siRNAs. The company's delivery technology, termed Chimerasomes, is based upon protein building blocks that can bind these therapeutic payloads and subsequently be triggered to self-assemble into nanocages, thereby encapsulating the polynucleic acids. The surface of the nanocages can subsequently be decorated with targeting moieties such as antibodies or with PK/ biodistribution modulating molecu...Show all

Chimeros is developing a biologics approach to enable delivery of polynucleotide therapeutics such as siRNAs. The company's delivery technology, termed Chimerasomes, is based upon protein building blocks that can bind these therapeutic payloads and s...Show all

Company (Alive / Active)

Phone: 858-622-0796

Fax:

3030 Bunker Hill Street
Suite 102
San Diego, 92109
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Chimeros $9.9M Aug 10, 2011
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Chimeros Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Prospect Venture PartnersVenture CapitalPalo Alto, California, United StatesDebt - V, Debt - IV, Debt - III, Debt - II, Debt, Series B - II
DFJ FrontierVenture CapitalBeverly Hills, California, United StatesDebt - V, Debt - IV, Debt - III, Debt - II, Debt, Series B - II, Series B
Arcturus CapitalVenture CapitalPasadena, California, United StatesSeries B - II
Undisclosed InvestorsOtherSeries A, Unattributed - II, Unattributed
See all 4 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and methods for treating b-cell malignancies Apr 09, 2007 Nov 29, 2011 Patent
Self-assembling nanoparticle drug delivery system May 25, 2005 Jun 21, 2011 Patent